首页> 外国专利> NEW INDAZOLE DERIVATIVE OR SALT THEREOF AND PRODUCTION INTERMEDIATE THEREOF, AND PROPHYLACTIC OR THERAPEUTIC AGENT OF CHORIORETINAL DENATURATION DISEASE BY USING THE SAME

NEW INDAZOLE DERIVATIVE OR SALT THEREOF AND PRODUCTION INTERMEDIATE THEREOF, AND PROPHYLACTIC OR THERAPEUTIC AGENT OF CHORIORETINAL DENATURATION DISEASE BY USING THE SAME

机译:新型吲哚衍生物或盐及其中间体的生产,以及通过使用相同的方法治疗角膜视网膜脱变的预防性或治疗性代理商

摘要

PROBLEM TO BE SOLVED: To provide a prophylactic or therapeutic agent of chorioretinal denaturation diseases without substantially accompanying neovascularization, e.g. atrophic age-related macular degeneration, retinitis pigmentosa, gyrate atrophy of the choroid and retina, and further chorioretinal disorders associated with the above diseases.SOLUTION: This compound expressed by formula (1) or its pharmaceutically acceptable salt has an inhibitory effect toward photo receptor cell death in a mouse light disorder model. Therefore, it is useful as the prophylactic or therapeutic agent of chorioretinal denaturation diseases without substantially accompanying neovascularization, eg. atrophic age-related macular degeneration, retinitis pigmentosa, gyrate atrophy of the choroid and retina and further chorioretinal disorders associated with the diseases.
机译:要解决的问题:提供脉络膜视网膜变性疾病的预防或治疗药物,而基本上不伴有新血管形成,例如与年龄相关的萎缩性黄斑变性,色素性视网膜炎,脉络膜和视网膜的旋回萎缩以及与上述疾病相关的其他脉络膜视网膜疾病小鼠光障碍模型中的细胞死亡。因此,可用作脉络膜视网膜变性疾病的预防剂或治疗剂,而基本上不伴有新血管形成。与年龄相关的萎缩性黄斑变性,色素性视网膜炎,脉络膜和视网膜的旋回萎缩以及与该疾病相关的其他脉络膜视网膜疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号